Unchained Labs Unveils LEA 9 Software Making Workflows Easy
Image credit: Unchained Labs
Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, has now released its LEA 9 software, making Freeslate and Junior automation systems way more accessible.
LEA, short for Laboratory Execution and Analysis Software, controls Freeslate and Junior systems, executes biologics and chemistry workflow designs, integrates third-party tools, and keeps all the data in one place.
LEA 9 adds a step-by-step workflow tool called Design Creator into the mix. There’s no coding, scripting or messing around with protocols. Scientists just drag and drop their workflow steps into place and they’re good to go. Design Creator also double checks each step to make sure it’s doable, so newbie users don’t have to worry about screwing things up.
“Freeslate and Junior already help researchers wipe out major hassles from their toughest workflows,” said Taegen Clary, VP of Marketing at Unchained Labs. “Automation can be insanely complicated, and really nerve wracking for casual users. LEA 9 makes lab automation totally easy and approachable for anyone.”
This article has been republished from materials provided by Unchained Labs. Note: material may have been edited for length and content. For further information, please contact the cited source.
Rapamycin Lotion Reduces Facial Tumors Caused by Tuberous SclerosisNews
Addressing a critical issue for people with a genetic disorder called tuberous sclerosis complex (TSC), doctors reported that a skin cream containing rapamycin significantly reduced the disfiguring facial tumors affecting more than 90 percent of people with the condition.READ MORE
Calidi Biotherapeutics, Inc. Announces its Corporate Vision in Groundbreaking Cancer Drug DevelopmentNews
Calidi Biotherapeutics, Inc., formerly StemImmune, Inc., a clinical‐stage biotherapeutics company at the forefront of oncolytic virus-based immunotherapies for cancer, announced a focused effort to advance its oncolytic virus drug development.READ MORE
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE